Autoantibodies against the human asialoglycoprotein receptor: Effects of therapy in autoimmune and virus-induced chronic active hepatitis
| العنوان: | Autoantibodies against the human asialoglycoprotein receptor: Effects of therapy in autoimmune and virus-induced chronic active hepatitis |
|---|---|
| المؤلفون: | K H Meyer zum Büschenfelde, Thomas Poralla, G. Gerken, Ulrich Treichel, H.W. Rotthauwe, S. Rossol |
| المصدر: | Journal of Hepatology. 19:55-63 |
| بيانات النشر: | Elsevier BV, 1993. |
| سنة النشر: | 1993 |
| مصطلحات موضوعية: | Adult, Male, Adolescent, Hepatitis, Viral, Human, medicine.medical_treatment, Asialoglycoproteins, Receptors, Cell Surface, Asialoglycoprotein Receptor, Autoimmune hepatitis, Autoimmune Diseases, Interferon, Immune Tolerance, Humans, Medicine, Child, Aged, Autoantibodies, Hepatitis, Chronic, Hepatitis, Hepatology, biology, business.industry, Autoantibody, Immunotherapy, Middle Aged, medicine.disease, Titer, Immunology, biology.protein, Female, Antibody, business, Viral hepatitis, Follow-Up Studies, medicine.drug |
| الوصف: | The hepatic asialoglycoprotein receptor (ASGPR) was recently identified as a target antigen for both humoral and cellular immune response in inflammatory liver diseases. Thereby anti-ASGPR autoantibodies directed against human substrate were closely associated with autoimmune chronic active hepatitis. The present study compares the occurrence, titer and immunoglobulin classification of anti-human(h-)-ASGPR antibodies in 23 patients with newly diagnosed autoimmune chronic hepatitis before and after initiation of immunosuppressive therapy to 22 patients with autoimmune hepatitis in remission. Additionally, 1-year follow-up examinations of 42 patients with HBsAg-positive chronic hepatitis and of 32 patients with chronic hepatitis C receiving recombinant interferon- α were included. Nineteen of 23 patients with newly diagnosed and 9/22 with autoimmune hepatitis in remission, 5/42 with untreated chronic hepatitis B and 5/32 patients with chronic hepatitis C exhibited anti-h-ASGPR at the beginning of the study. In autoimmune hepatitis anti-h-ASGPR were found in higher titers (median > 1:1000) than in viral hepatitis (maximum 1:400). After initiation of immunosuppressive therapy in autoimmune hepatitis anti-h-ASGPR decreased sharply. Eight of 19 patients eliminated anti-h-ASGPR within 18 months in contrast to 11 patients with persistent anti-h-ASGPR titer over 18 months and longer. Anti-h-ASGPR with maximum titer of 1:600 were detected in 5 patients with chronic hepatitis B (transiently in 4/5 patients) and in 2 patients with chronic hepatitis C during interferon- α . Anti-h-ASGPR were from immunoglobulin classes IgG and IgM in cases with untreated autoimmune hepatitis and chronic hepatitis B and C exhibiting mainly IgG 2 -subclass in autoimmune and IgG 4 in viral hepatitis. Lower titer (up to 1:400) anti-h-ASGPR in autoimmune hepatitis were exclusively from IgG-type in contrast to viral hepatitis, respectively, where both IgG and IgM-class anti-h-ASGPR were found despite lower titer values. Thus, our results clearly indicate different patterns of anti-h-ASGPR occurrence, titer and immunoglobulin classes in patients with either autoimmune or viral hepatitis, respectively. This suggests different pathways of induction and perpetuation of autoantibody formation in inflammatory liver diseases in man. |
| تدمد: | 0168-8278 |
| DOI: | 10.1016/s0168-8278(05)80176-x |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c39ce20fcfaff7115169d2c053fb18ef https://doi.org/10.1016/s0168-8278(05)80176-x |
| Rights: | CLOSED |
| رقم الانضمام: | edsair.doi.dedup.....c39ce20fcfaff7115169d2c053fb18ef |
| قاعدة البيانات: | OpenAIRE |
كن أول من يترك تعليقا!